India is witnessing a rise in COVID-19 cases, with active infections surpassing 1,000 as of May 26, up sharply from 257 the previous week. Seven deaths were reported in the past week. Most cases are mild and do not require hospitalisation. The surge is driven by two new Omicron sub-variants, LF.7 and NB.1.8, while the JN.1 strain remains dominant. These new variants are classified by WHO as "Variants Under Monitoring," indicating ongoing observation but no immediate cause for concern. Symptoms are similar to flu and earlier Omicron strains, including sore throat, fatigue, mild cough, and fever, with most patients recovering at home. The rise is concentrated in states like Kerala, Maharashtra, Delhi, Tamil Nadu, and Karnataka. India’s extensive vaccination campaign, with over 2.2 billion doses administered, continues to be crucial in preventing severe illness, hospitalisation, and death. Health authorities urge eligible individuals to complete vaccinations and boosters to mitigate the impact of the current mild surge.
first published: May 27, 2025 02:19 pm
A collection of the most-viewed Moneycontrol videos.

New Year Party Or Year-End Blues? Bulls In Focus| Top Stock Bets & 2026 Outlook| Opening Bell Live

Nifty Trades in a Narrow 100-Point Range on 2025’s Final F&O Expiry | Closing Bell Live

Small-Caps & Risk: What Investors Often Miss

Nifty’s Best Case Target & Top Stock Bets For 2026| IPO Wave Set To Get Bigger| Opening Bell Live
You are already a Moneycontrol Pro user.

